Aim: To identify the relationship between the radiosensitivity of oral cancers and to evaluate the dose-dependent relationship of nuclear abnormalities by serial cytology during fractionated radiotherapy in head and neck cancer patients. Materials and Methods: 30 patients with histologically proven cases of squamous cell carcinoma were included in the study. Serial scrape smear were taken from the tumor before and during radiotherapy (0 to 24 Gy), and stained with Giemsa and May Grunwald's stain and frequency of micronucleated, binucleated and multinucleated cells were evaluated with the help of light microscope. The counts were expressed per 1000 uninucleated cells.
INTRODUCTION
cancer cells showed significant hyperchromasia. [8] Even though micronucleation had been reported The term oral cancer generally refers to squamous as a radiation-related change [9] and later came to cell carcinoma (SCC) of oral mucosal origin, which be accepted as a reliable indicator for measuring accounts for, more than 90% of all malignancies radiation exposure, but cytologists had not incor of this location. [1] The mainstay of current therapy porated it in their evaluation of smears. for oral cancer is surgery or radiation. Variability in intrinsic radiosensitivity is an important facPresence of micronucleated and multinucleated tor that determines the control of cancers with cell in untreated tumors have been reported by radiotherapy. [2] [3] [4] many, [10] [11] [12] but they have been used rather as markers of radiosensitivity or chemosensitivity. Evaluation of radiation-induced cellular changes
As both micronucleation need cell division or at with a view to predict radiosensitivity has intertempted cell division for their induction. Hence ested many investigators since such changes they may be considered as markers of prolifera were first found in biopsy material in 1935. [5] tion too, though no serious attempt has been Cytologic evaluation of irradiation effects on oral made to evaluate them from that aspect. Cell mucosa was first reported in 1957 [6] and on oral structure studies have shown that both cancer in 1959. [7] By the 1960s the nuclear mormicronucleated and multinucleated cells are phologic changes that were to be evaluated by nonclonogenic. Yet, they are not physically dead, cytology became well-established and included but continues to divide a few times. pyknosis, karyorrhexis, karyolysis, enlargement, crenation of the nuclear membrane and
The micronucleus assay is a widely used tech multinucleation. Both malignant and benign cells nique for monitoring and evaluation of the were known to show the same changes, although clastogenic effect of chemical, radiological and other damaging agents in various types of cells. [13] [14] [15] [16] [17] The ability of this method to evaluate the response of individual cells has led to an increase in its application in recent years. The micronucleus assay is routinely used as a biological dosimeter [13, [18] [19] [20] and can be a useful tool in the evaluation of cell sensitivity to ionizing radiation with implications for tumor therapy. [21, 22] The aim of the present study was to find out whether there is any relationship with the frequency of nuclear anomalies in the smears of oral cancer patients with the disease and whether the such frequency could serve as an indicator for the treatment outcome.
MATERIALS AND METHODS
The present study has been carried out on 30 patients with biopsy proven malignancies of head and neck cancer stage II, III, IV. Patients of head and neck cancers were classified according to UICC classification. Patients were treated by external telecobalt beam radiotherapy. Pretreatment scrape smears were collected from the tumor of each patient. Sub sequently, 3-4 smears were collected from each patient af ter delievery of various fractions (2 Gy/fraction), usually af ter 2, 7 and 12 fractions. Care was taken from the tumor, avoiding adjacent normal areas (smears were usually not collected after 12 fractions because radiation mucositis made it difficult to distinguish tumor from normal tissue). Scrap ing was done with previously wetted spatula and material spread on slide, then material was fixed with the help of methanol and stained with Giemsa and May-Grunwald's stain. After dehydration, the slides were mounted in DPX and were evaluated under light microscope.
The following abnormally nucleated cells were evaluated -1. Micronucleation: intracytoplasmic, DNA staining bod ies found in the same plane as the main nucleus with the same or slightly lesser intensity, one third to one fifth the size of the main nucleus, placed within two nuclear diameters from the main nucleus but distinctly separate from it. 2. Binucleation: two nuclei in a single cell with no micro nucleus or budding of the nucleus. 3. Multinucleation: more than two nuclei in a single cell.
Cells were counted separately for the number of micronu clei, multinuclei and binucleated cells. Around 500-1000 cells were evaluated from the samples collected on each frac tion and the results were expressed in terms of 1,000 tumor cells with normal nucleated cells. In each group, the mean of micronucleated cells, binucleated cells and multinucle ated cells were calculated at each dose. Variance was analyzed within the group and p-value was calculated. Pa tient's characteristic is given in Table 1 .
RESULTS
All the parameters analyzed showed increase with cumu- After 24 Gy, the micronucleated cells were 3.7 times, binucleated cells were about twice and multinucleated cells were 3.6 times than the pretreatment values. After analy- sis of p-value, all such abnormal cells showed significant difference (p < 0.0001) with respect to normal subjects.
DISCUSSION
Detailed studies of tumors in the past few years have re vealed that even tumors which are classified into the same category by the pathologist are very heterogenous in their biological attributes. [23] [24] [25] [26] [27] [28] As success of tumor and normal tissue, rapid assay systems for determination of radiation response of various tissues are urgently required.
Results from the present study showed a noticeable nu clear change occurred during the radiation treatment of oral cancer cells. On analysis, all of them showed significant dose dependent increase. Micronuclei are acentric, chromatid or chromosome fragments that lag behind during mitosis and fail to be incorporated into the main nucleus of the daugh ter cells after cell division. In fact it is an accepted test for monitoring toxicity of chemicals [29] and effectiveness of chemopreventive agents and radiotherapy against cancer [30] since ionizing radiation causes dose dependent mitotic de lay in exposed cells. Micronuclei are due to damage to the chromosome leading to loss of genetic material. Micronucleation assay in cultured lymphocytes by the cy tokinesis-blocked method is recommended as a biologic dosimetre for radiation exposure. [31] In the present study, the frequency of micronucleated cells showed a statistically significant increase with radiation, the count of 24 Gy was more than 3.7 times the pretreat ment count. The high variance in the counts at each dose point suggests the presence of a high degree of intertumoral heterogenicity in micronucleus induction. This suggests that it may have the potential for use as a predic tive test for radiosensitivity.
At least with regard to proliferating tissues, the micronu cleus assay seems to be helpful when it comes to the de termination of radiation sensitivity. This is mainly due to the long known and often confirmed observation that mi cronuclei are indicators of the extent of cell death. [32] [33] [34] Micronucleation can occur if there is damage to and inter ference with the functioning of the centrioles, pericentriolar matrix or cell membrane. Radiation-induced multinucleation have been noted in animal expriments. [35] Experiments with proton microbeams showed that irradiation of cytoplasm (with the nucleus shielded) results in damage to the centrioles leading to micronucleation. [36] Damage to pericentriolar matrix can lead to multipolar mitosis and multinucleation. [37] The frequency of micronuclei in the present study increased with the increase in radiation dose. Zamboglou et al. (1991) observed a pronounced increase in the number of micronu clei in cells of recurrent heads and neck carcinoma after com bined radiotherapy and intratumoral instillation of mitroxantrone. [13] This increase was clearly greater than that expected from the addition of the single effects. The marked response with regard to micronucleus formation was ac companied by an improved tumor remission.
Similarly, a dose-dependent increase in the frequency of micronuclei in vivo has been reported in polychromatic erythrocytes [38, 39] and in bone marrow cells [40, 41] of mice after exposure to various doses of X or g-radiation. Mitchell and Norman (1987) and Ramalho et al. (1988) have reported a dose-dependent increase in the counts of micronuclei in the lymphocytes of human peripheral blood exposed to low doses of X-rays. [42, 43] Radiation-induced peroxidation of lipids in the cell mem brane can cause structural and functional alterations to it. If the damage is severe, there will be cytokinesis block re sulting in the formation of binucleated cells and further division of one or both nuclei leads to multinucleation. The present study shows a significant increase in multinucleation during fractionated radiotherapy as com pared to pretreatment values. Multinucleated cells are also incapable of giving rise to new colonies [37] and therefore can be considered as dead cells. Thus, evaluation of multinu cleated cells also suggest that it is likely to provide infor mation about radiosensitivity.
CONCLUSION
The present study concludes that micronucleus assay is a very useful tool in the assessment of biological damage that can help to identify tumor radiosensitivity. This may be use ful in the development of the in vivo models of cell killing in human cancer radiotherapy. The results of micronucleus assay may be helpful for the decision on the appropriate method of treatment, they allow to monitor the response to the treatment, and they may be useful in giving progno sis of the final outcome of the therapy.
